Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)


Matzinger O., Heimsoth I., Poortmans P., Collette L., Struikmans H., Van Den Bogaert W., ...Daha Fazla

ACTA ONCOLOGICA, cilt.49, ss.24-34, 2010 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 49 Konu: 1
  • Basım Tarihi: 2010
  • Doi Numarası: 10.3109/02841860903352959
  • Dergi Adı: ACTA ONCOLOGICA
  • Sayfa Sayıları: ss.24-34

Özet

Introduction. The EORTC 22922/10925 trial investigated the potential survival benefit and toxicity of elective irradiation of the internal mammary and medial supraclavicular (IM-MS) nodes Accrual completed in January 2004 and first results are expected in 2012. We present the toxicity reported until year 3 after treatment.